Detalhe da pesquisa
1.
A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM).
J Neurooncol
; 165(3): 499-507, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015376
2.
18F-fluciclovine PET/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot study.
J Neurooncol
; 163(3): 647-655, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37341842
3.
Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade glioma.
J Neurooncol
; 156(3): 499-507, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064450
4.
Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomas.
J Neurooncol
; 158(3): 341-348, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35486307
5.
Phase II study of Dovitinib in recurrent glioblastoma.
J Neurooncol
; 144(2): 359-368, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292802
6.
Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution.
J Neurooncol
; 131(3): 555-563, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27864703
7.
The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies.
J Neurooncol
; 133(2): 357-368, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28434110
8.
A cure is possible: a study of 10-year survivors of brain metastases.
J Neurooncol
; 129(3): 545-555, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27456950
9.
Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline.
J Clin Oncol
; 40(20): 2271-2276, 2022 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35561283
10.
Sex-Specific Differences in Low-Grade Glioma Presentation and Outcome.
Int J Radiat Oncol Biol Phys
; 114(2): 283-292, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667529
11.
SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors.
Neuro Oncol
; 23(11): 1835-1844, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34174071
12.
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.
J Neurooncol
; 98(1): 93-9, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19960228
13.
Targeted Therapy After Brain Radiotherapy for BRAF-Mutated Melanoma With Extensive Ependymal Disease With Prolonged Survival: Case Report and Review of the Literature.
Front Oncol
; 9: 168, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972290
14.
Risk Factors for Progression Among Low-Grade Gliomas After Gross Total Resection and Initial Observation in the Molecular Era.
Int J Radiat Oncol Biol Phys
; 104(5): 1099-1105, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31022510
15.
Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma.
Int J Radiat Oncol Biol Phys
; 105(5): 1106-1112, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31461674
16.
Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases.
J Neurosurg
; : 1-9, 2019 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30660120
17.
Evaluation of Prognostic Factors for Early Mortality After Stereotactic Radiosurgery for Brain Metastases: a Single Institutional Retrospective Review.
Neurosurgery
; 83(1): 128-136, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28673040
18.
Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
J Neurosurg
; 131(2): 489-499, 2018 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30485180
19.
Risk Factors for Malignant Transformation of Low-Grade Glioma.
Int J Radiat Oncol Biol Phys
; 100(4): 965-971, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29485076
20.
Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases.
Int J Radiat Oncol Biol Phys
; 67(1): 240-3, 2007 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17056192